Research ArticleArticle
Identification of Clinically Used Drugs That Activate Pregnane X Receptors
Sunita J. Shukla, Srilatha Sakamuru, Ruili Huang, Timothy A. Moeller, Paul Shinn, Danielle VanLeer, Douglas S. Auld, Christopher P. Austin and Menghang Xia
Drug Metabolism and Disposition January 2011, 39 (1) 151-159; DOI: https://doi.org/10.1124/dmd.110.035105
Sunita J. Shukla
National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland (S.J.S., S.S., R.H., P.S., D.V.L., D.S.A., C.P.A., M.X.); and Celsis in Vitro Technologies, Halethorpe, Maryland (T.A.M.)
Srilatha Sakamuru
National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland (S.J.S., S.S., R.H., P.S., D.V.L., D.S.A., C.P.A., M.X.); and Celsis in Vitro Technologies, Halethorpe, Maryland (T.A.M.)
Ruili Huang
National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland (S.J.S., S.S., R.H., P.S., D.V.L., D.S.A., C.P.A., M.X.); and Celsis in Vitro Technologies, Halethorpe, Maryland (T.A.M.)
Timothy A. Moeller
National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland (S.J.S., S.S., R.H., P.S., D.V.L., D.S.A., C.P.A., M.X.); and Celsis in Vitro Technologies, Halethorpe, Maryland (T.A.M.)
Paul Shinn
National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland (S.J.S., S.S., R.H., P.S., D.V.L., D.S.A., C.P.A., M.X.); and Celsis in Vitro Technologies, Halethorpe, Maryland (T.A.M.)
Danielle VanLeer
National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland (S.J.S., S.S., R.H., P.S., D.V.L., D.S.A., C.P.A., M.X.); and Celsis in Vitro Technologies, Halethorpe, Maryland (T.A.M.)
Douglas S. Auld
National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland (S.J.S., S.S., R.H., P.S., D.V.L., D.S.A., C.P.A., M.X.); and Celsis in Vitro Technologies, Halethorpe, Maryland (T.A.M.)
Christopher P. Austin
National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland (S.J.S., S.S., R.H., P.S., D.V.L., D.S.A., C.P.A., M.X.); and Celsis in Vitro Technologies, Halethorpe, Maryland (T.A.M.)
Menghang Xia
National Institutes of Health Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland (S.J.S., S.S., R.H., P.S., D.V.L., D.S.A., C.P.A., M.X.); and Celsis in Vitro Technologies, Halethorpe, Maryland (T.A.M.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Identification of Clinically Used Drugs That Activate Pregnane X Receptors
Sunita J. Shukla, Srilatha Sakamuru, Ruili Huang, Timothy A. Moeller, Paul Shinn, Danielle VanLeer, Douglas S. Auld, Christopher P. Austin and Menghang Xia
Drug Metabolism and Disposition January 1, 2011, 39 (1) 151-159; DOI: https://doi.org/10.1124/dmd.110.035105
Research ArticleArticle
Identification of Clinically Used Drugs That Activate Pregnane X Receptors
Sunita J. Shukla, Srilatha Sakamuru, Ruili Huang, Timothy A. Moeller, Paul Shinn, Danielle VanLeer, Douglas S. Auld, Christopher P. Austin and Menghang Xia
Drug Metabolism and Disposition January 1, 2011, 39 (1) 151-159; DOI: https://doi.org/10.1124/dmd.110.035105
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement